Clinical Trial Update: A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

View source ↗

Summary

This clinical trial update reports safety findings from a follow-up evaluation of participants in a Phase 1 study of BMS-986094 (INX-08189), including healthy v…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BMS-986094 (INX-08189) (BMS-986094)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Healthy, Hepatitis C | Status: COMPLETED